Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Intermittent claudication: an historical perspective

M. Condorelli* and G. Brevetti

Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University di Napoli Federico II, Naples, Italy

* Correspondence: M. Condorelli MD, Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University di Napoli Federico II, via Sergio Pansini 5, I-80131 Naples, Italy.

Abstract

The present review addresses the history of intermittent claudication in terms of pathogenetic and therapeutic approach. The reduced blood supply to the affected limb was initially explained by ‘vasospasm theory’, and vasodilators were the first drugs to be used. However, the demonstration that they induce the blood steal phenomenon led to the demise of vasodilating therapy. The 1970s marked the shift in interest from ‘vessel’ to ‘blood’, and drugs that improve blood rheology were introduced. In the 1990s, research focused on the metabolic regulation of the ischaemic muscle, and the ‘metabolic therapy’ has emerged as a new approach with which to improve walking capacity in claudicant patients.

Key Words: Intermittent claudication • pathophysiology of intermittent claudication • peripheral artery disease • therapy of intermittent claudication


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.